| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |